{"id": "1367023659391590403", "creation": 1614758813.0, "user_id": "585807608", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 4, "reply_count": 3, "like_count": 12, "quote_count": 2}}, "text": "Quick follow-up on this morning\u2018s oral #COVID19 #vaccine Q on @sarahjulianotts @BBCNottingham #breakfastshow. At least one UK company is interested, but I suspect nasal administration would be more likely route to be pursued to induce mucosal immunity...\nhttps://t.co/WJ23zTYSRv", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#BREAKFASTSHOW"]}